Biogen Inc. BIIB, a well-known name in the multiple sclerosis (MS) market, will report first-quarter 2018 results on Apr 24, before the market opens. Last quarter, the company delivered a negative earnings surprise of 3.31%.
What's in Store for Biogen (BIIB) This Earnings Season?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться